FilmArray Respiratory Panel Assay: Comparison of Nasopharyngeal Swabs and Bronchoalveolar Lavage Samples

FilmArray Respiratory Panel Assay: Comparison of Nasopharyngeal Swabs and Bronchoalveolar Lavage Samples
复制标题

DOI:
10.1128/jcm.01516-15
复制
发表时间:
2015-12-01
影响因子:
9.4
通讯作者:
Grys, Thomas E.
Grys, Thomas E.
中科院分区:
医学2区
文献类型:
--
作者:
Azadeh, Natalya;Sakata, Kenneth K.;Grys, Thomas E.

文献摘要

被引文献

相似文献

FilmArray呼吸面板(FARP)可靠、快速地识别出17种病毒和3种细菌病原体。对许多有呼吸道症状的患者进行鼻咽拭子FARP (NP FARP)。对于急性疾病或免疫功能受损或未能改善的患者,除NP FARP外,还进行支气管肺泡灌洗样本FARP (BAL FARP)。到目前为止,还没有研究将BAL FARP的产量与NP FARP的产量进行比较。我们回顾性研究了2013年6月至2014年5月期间所有在NP FARP术后7天内进行BAL FARP的患者。收集了人口统计学信息、合并症、FARP结果和BAL液的所有微生物学数据。86例患者在NP FARP后7天内进行了BAL FARP(平均1.6例,中位数1例)。其中66例(77%)具有一致的BAL和NP FARP结果,15例(23%)从NP和BAL FARP中鉴定出相同的病原体,51例(77%)具有一致的阴性FARP结果。86例患者中有18例(21%)从NP - FARP检测到病原体;其中,15例(83%)在随后的BAL FARP上匹配一致,其余3例BAL FARP阴性。86例患者中有17例(20%)从BAL farp中鉴定出了NP farp未检测到的病原体;其中,16例(94%)初始NP farp为阴性。这些数据表明,一旦通过NP FARP鉴定出病原体,随后的BAL FARP不太可能添加新的微生物学信息。然而,在NP FARP阴性后7天内进行BAL FARP可能提供新的、有用的微生物学信息。
The FilmArray respiratory panel (FARP) reliably and rapidly identifies 17 viruses and 3 bacterial pathogens. A nasopharyngeal swab FARP (NP FARP) is performed for many patients with respiratory symptoms. For patients who are acutely ill or immuno-compromised or fail to improve, a bronchoalveolar lavage sample FARP (BAL FARP) is performed in addition to the NP FARP. To date, no studies have compared the yield of a BAL FARP with that of an NP FARP. We retrospectively studied all patients who had a BAL FARP within 7 days after an NP FARP between June 2013 and May 2014. Demographic information, comorbidities, FARP results, and all microbiologic data from BAL fluid were collected. Eighty-six patients had a BAL FARP performed within 7 days (mean, 1.6; median, 1) after an NP FARP. Of these, 66 (77%) had concordant BAL and NP FARP results: 15 (23%) had the same pathogen identified from the NP and BAL FARPs, and 51 (77%) had concordant negative FARP results. In 18 of the 86 patients (21%), a pathogen was detected from the NP FARP; of these, 15 (83%) had a concordant match on a subsequent BAL FARP, and the remaining 3 had negative BAL FARPs. In 17 of the 86 patients (20%), pathogens were identified from the BAL FARPs that were not detected by the NP FARPs; of these, 16 (94%) had initial negative NP FARPs. The data suggest that once a pathogen is identified by an NP FARP, a subsequent BAL FARP is unlikely to add new microbiologic information. However, a BAL FARP may provide new, useful microbiologic information when performed within 7 days after a negative NP FARP.